CHUGAI PHARMACEUTICAL CO., LTD.(4519) Summary
4519
TSE Prime
CHUGAI PHARMACEUTICAL CO., LTD.
Result
ー
6,933
JPY
-242
(-3.37%)
Aug 14, 3:30 pm JST
43.52
USD
Aug 14, 2:30 am EDT
PER
ー
PBR
5.63
Yield
1.90%
Margin Trading Ratio
54.23
PTS
outside of trading hours
6,930
Aug 14, 6:37 pm JST
Stock Price
Aug 14, 2026
Opening
Aug 14, 9:00 am
7,121
JPY
44.66
USD
Previous Close
Aug 13
7,175
JPY
45.01
USD
High
Aug 14, 9:00 am
7,121
JPY
44.66
USD
Low
Aug 14, 10:33 am
6,852
JPY
42.98
USD
Volume
4,618,700
Trading Value
0.03T
JPY
0.20B
USD
VWAP
6953.3
JPY
43.66
USD
Minimum Trading Value
693,300
JPY
4,352
USD
Market Capitalization
11.64T
JPY
0.07T
USD
Number of Trades
10,149
Opening
Aug 14, 5:05 pm
6,933
JPY
Previous Close
Aug 14
6,943.1
JPY
High
Aug 14, 5:05 pm
6,933
JPY
Low
Aug 14, 6:37 pm
6,930
JPY
Volume
200
Trading Value
1.38M
JPY
VWAP
6,931.50
JPY
Minimum Trading Value
ー
Market Capitalization
ー
Number of Trades
ー
PTS Stock Price
Liquidity & Number of Trades
As of Aug 14, 2026
Liquidity
Liquidity Grade
| Liquidity | Number Of Trades | Distribution |
|---|---|---|
| High | Over 1,000 | 13.9% |
| Slightly-High | 400 to 1,000 | 18.5% |
| Mid | 50 to 400 | 39.0% |
| Slightly-Low | 10 to 50 | 17.6% |
| Low | Less than 10 | 11.0% |
High
1-Year Average
7,560
1-Year High
Apr 27, 2026
27,979
Margin Trading
| Date | Short Interest | Long Margin Positions | Ratio |
|---|---|---|---|
| Aug 7, 2026 | 26,000 | 1,410,000 | 54.23 |
| Jul 31, 2026 | 28,900 | 1,367,200 | 47.31 |
| Jul 24, 2026 | 40,300 | 1,158,900 | 28.76 |
| Jul 17, 2026 | 22,400 | 1,197,700 | 53.47 |
| Jul 10, 2026 | 33,100 | 1,159,600 | 35.03 |
Company Profile
CHUGAI PHARMACEUTICAL CO., LTD. is a major pharmaceutical company. As a subsidiary of Roche, it has expanded its product line, including Tamiflu. The company's main focus is on anticancer drugs and rheumatoid arthritis treatments.
Sector
Pharmaceuticals
CHUGAI PHARMACEUTICAL CO., LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and sales of pharmaceuticals, operating under the Swiss pharmaceutical giant Roche. In Japan, the company sells its own products through authorized dealers, while overseas it has sales bases in Europe, Taiwan, China, and other regions. Manufacturing is carried out at the company's domestic and international factories, as well as through contracted partners. As a member of the Roche Group, Chugai purchases some raw materials from Roche and distributes some products internationally through Roche's network. The company focuses on developing innovative drugs, particularly in the fields of cancer treatment and rheumatoid arthritis, while pursuing global business expansion.